Balyasny Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.1M | Buy |
641,299
+54,037
| +9% | +$5.32M | 0.1% | 201 |
|
|
2025
Q1 | $54.4M | Buy |
587,262
+170,566
| +41% | +$15.8M | 0.09% | 216 |
|
|
2024
Q4 | $37.8M | Sell |
416,696
-57,576
| -12% | -$5.23M | 0.06% | 318 |
|
|
2024
Q3 | $45.8M | Buy |
474,272
+434,663
| +1,097% | +$41.9M | 0.07% | 251 |
|
|
2024
Q2 | $3.64M | Buy |
+39,609
| New | +$3.64M | 0.01% | 916 |
|
|
2023
Q4 | – | Sell |
-27,500
| Closed | -$2.57M | – | 1890 |
|
|
2023
Q3 | $2.57M | Buy |
+27,500
| New | +$2.57M | 0.01% | 944 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1835 |
|
|
2020
Q2 | – | Sell |
-19,794
| Closed | -$3.63M | – | 934 |
|
|
2020
Q1 | $3.63M | Sell |
19,794
-903
| -4% | -$166K | 0.04% | 414 |
|
|
2019
Q4 | $3.46M | Sell |
20,697
-105,943
| -84% | -$17.7M | 0.02% | 570 |
|
|
2019
Q3 | $16.6M | Buy |
+126,640
| New | +$16.6M | 0.11% | 251 |
|
|
2019
Q2 | – | Sell |
-12,267
| Closed | -$1.51M | – | 1310 |
|
|
2019
Q1 | $1.51M | Sell |
12,267
-1,400
| -10% | -$173K | 0.01% | 803 |
|
|
2018
Q4 | $1.6M | Sell |
13,667
-40,406
| -75% | -$4.73M | 0.01% | 680 |
|
|
2018
Q3 | $6.76M | Sell |
54,073
-33,889
| -39% | -$4.23M | 0.03% | 486 |
|
|
2018
Q2 | $7.52M | Sell |
87,962
-165,180
| -65% | -$14.1M | 0.03% | 472 |
|
|
2018
Q1 | $15.3M | Buy |
253,142
+222,964
| +739% | +$13.5M | 0.06% | 348 |
|
|
2017
Q4 | $1.59M | Buy |
30,178
+18,652
| +162% | +$983K | 0.01% | 979 |
|
|
2017
Q3 | $645K | Sell |
11,526
-111,636
| -91% | -$6.25M | ﹤0.01% | 1071 |
|
|
2017
Q2 | $7.74M | Buy |
+123,162
| New | +$7.74M | 0.03% | 518 |
|